There are piles of close to zero cost options and early issued shares that are tradeable - management primarily, I think. I presume that is what is occurring.
But as far as the company goes, I don’t see why it can’t say how the trials are going structurally - ie, has Covid disrupted things, is it going to delay results, is there anything else going on etc? Something. Anything. It’s just crickets otherwise.
EBR news, page-26
Add EBR (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.17 |
Change
0.065(5.91%) |
Mkt cap ! $358.9M | |||
| Open | High | Low | Value | Volume |
| $1.10 | $1.18 | $1.10 | $384.5K | 337.5K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 1300 | $1.15 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.17 | 607 | 1 |
View Market Depth
| Last trade - 16.10pm 03/06/2024 (20 minute delay) ? |
|
|||||
|
Last
$1.16 |
Change
0.065 ( 5.45 %) |
||||
| Open | High | Low | Volume | ||
| $1.14 | $1.18 | $1.12 | 40088 | ||
| Last updated 15.31pm 03/06/2024 ? | |||||
| EBR (ASX) Chart |